©2024 Stanford Medicine
SEP-SEQ Trial - Determining the Etiology of Sepsis Using an Infectious Disease Diagnostic Sequencing Assay
Not Recruiting
Trial ID: NCT02730468
Purpose
The purpose of this study is to evaluate the performance of the Karius Infectious Diseases
Plasma Sequencing Assay in patients who present to the emergency room with sepsis.
Official Title
SEP-SEQ Trial - Determining the Etiology of Sepsis Using an Infectious Disease Diagnostic Sequencing Assay
Stanford Investigator(s)
Samuel Yang, MD, FACEP
Associate Professor of Emergency Medicine (Adult Clinical/Academic)
Eligibility
Inclusion Criteria:
1. 18 years or older
2. Meet 2 of 4 sepsis criteria
1. Temperature > 38C or < 36C
2. Heart rate > 90 bpm
3. Respiratory rate >20 or PaCO2 <32mmHg
4. WBC >12000/µL or < 4000/µL or > 10% bands
Exclusion Criteria:
1. Inability to understand instructions and comply with study-related procedures
2. Any condition that in the opinion of the treating physician will prevent the subject
from completing the study.
Not Recruiting
Contact Information
Stanford University
School of Medicine
300 Pasteur Drive
Stanford,
CA
94305